Month: October 2019

Washington University in St. Louis is committed to supporting faculty, students and staff wherever they are on their entrepreneurial journey — and is especially invested in supporting women bringing their ideas and discoveries from the lab to the marketplace. A terrific example of that commitment begins in St. Louis next year, with Equalize 2020.

Cara Cipriano, MD, assistant professor of orthopedic surgery at Washington University School of Medicine in St. Louis, and Kate Gerull, a medical student at the school, received a grant from the American Medical Association (AMA) Women Physicians Section and the AMA Foundation to conduct a multicenter study of gender factors that may influence students’ decisions to pursue careers in orthopedic surgery.

Contrary to the belief that drinking can literally shrink one’s brain, a new study that includes researchers from Arts & Sciences suggests that a small brain might be a risk factor for heavier alcohol consumption.

Medical scientists at the Taylor Family Institute for Innovative Psychiatric Research have pioneered the use of neurosteroid drugs to treat psychiatric illness.

Images from in and around the Washington University campuses.

Researchers in Jonathan Barnes’ laboratory in Arts & Sciences have developed a new light-sensitive hydrogel with improved biocompatibility compared with similar materials. Down the line, these materials may be particularly suited for medical uses like prosthetics or transplantable organs.

Mothers in low-income neighborhoods report more physical and social barriers that discourage them from allowing their children to play outside, according to new research from the Brown School at Washington University in St. Louis.

Kevin Moeller, professor of chemistry in Arts & Sciences, will receive a 2020 Arthur C. Cope Scholar Award for excellence in organic chemistry. The Cope Scholar Award is a national award sponsored by the Arthur C. Cope Fund and administered by the American Chemical Society. Only 10 recipients each year receive the award.

A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

Ten researchers at Washington University in St. Louis have received funding from the Longer Life Foundation, a cooperative effort between the School of Medicine and the Reinsurance Group of America (RGA). The grants help junior investigators launch research projects and assist more established researchers as they extend their investigations into new areas. The foundation supports research […]